Aqueous cilostazol preparation for injection

摘要

Addition of a cyclodextrin compound to the cilostazol aqueous pharmaceutical preparation for parenteral use which comprises cilostazol or a pharmacologically acceptable salt thereof as an active ingredient can increase water solubility of cilostazol or a pharmacologically acceptable salt thereof, giving an aqueous pharmaceutical preparation for parenteral use of cilostazol or a pharmacologically acceptable salt thereof, of which the stability with time in the liquid state is improved.